Angiosoma Overview

  • Status
  • Public
  • Employees
  • 1
Employees
  • Stock Symbol
  • SOAN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.01
  • (As of Wednesday Closing)

Angiosoma General Information

Description

AngioSoma Inc is a US-based is a wellness company. Through its subsidiary, the company is dedicated to bringing innovative, effective, and high-quality supplement products for the medical, wellness, and adult-use markets. Its products comprise OmniCath I and II and Nutraceuticals.

Contact Information

Website
www.angiosoma.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
PINX
Primary Office
  • 14001 Walden Road
  • Suite 600
  • Montgomery, TX 77356
  • United States
+1 (832) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiosoma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $6.42M 445M 7.33M

Angiosoma Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019 FY 2018 30-Sep-2018
EV 2,730 2,730 4,094 4,689
Revenue 0 0 1 1
EBITDA (302) (302) (314) (713)
Net Income (542) (542) (675) (817)
Total Assets 90 90 142 125
Total Debt 215 215 173 345
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angiosoma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angiosoma‘s full profile, request access.

Request a free trial

Angiosoma Executive Team (1)

Name Title Board Seat Contact Info
Alex Blankenship President & Chief Executive Officer
To view Angiosoma’s complete executive team members history, request access »

Angiosoma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiosoma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000 07-Jun-2016 000000000000000000 Energy Exploration
To view Angiosoma’s complete acquisitions history, request access »

Ready to get started?

Request a free trial